Fact CheckerSign in

NCT05778006Recruiting

Multi-Center Registry for ME/CFS

Multi-Center Registry for ME/CFS, Including ME/CFS Following Epstein-Barr Virus-Associated Infectious Mononucleosis (EBV-IM) or Coronavirus Disease 2019 (Covid-19)

Source: ClinicalTrials.gov · Last updated 10 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The ME/CFS study (MECFS-R) aims to create a large-scale registry that provides data on epidemiology, phenotypes, and disease trajectories of and health care for ME/CFS at any age in Germany, which can be used for future clinical trials.

Status (registry)
Recruiting
Study type
Observational
Enrollment
650 (estimated)
First submitted
20 Mar 2023
Start date
31 May 2022
Primary completion date
31 May 2052
Lead sponsor
Technical University of Munich
NCT number
NCT05778006

What you commit to

  • Study type: Observational
  • Planned participants: 650
  • From 31 May 2022 to the primary completion date, 31 May 2052
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • No ME/CFS (ICD-10 G93.3)
  • No informed consent

Who the study is looking for

  • ME/CFS diagnosis (ICD-10 G93.3) based on internationally established criteria
  • Informed consent by patients and/or guardian(s)

Age in the registry: 0 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital
Coordinator of this site? Confirm its status
MunichGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.